Defining Robust Predictors of Chemotherapy Related Cardiotoxicity

Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

NCT03425058 ·Status: COMPLETED

Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer

NCT05318794 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Prospective Evaluation and Molecular Profiling in People With Gastric Tumors

NCT03027427 ·Status: COMPLETED

A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy

NCT03086291 ·Status: UNKNOWN ·Phase: PHASE1

Metastatic Gastric Cancer FFCD 03-07

NCT00374036 ·Status: COMPLETED ·Phase: PHASE3

First-Line and Neoadjuvant Immunotherapy for Gastric Cancer

NCT06727981 ·Status: RECRUITING

A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer

NCT01836120 ·Status: UNKNOWN ·Phase: PHASE2

Rare Subtypes of Gastrointestinal Cancers

NCT04838327 ·Status: RECRUITING

Impact of Patient Reported Outcomes for Pre-chemotherapy Medical Decision in Day Patients With Digestive Cancer

NCT04008056 ·Status: COMPLETED ·Phase: NA

Nutrition-support-team Based Intervention in Patients With Advanced Gastrointestinal Cancer

NCT03631537 ·Status: UNKNOWN ·Phase: NA

Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer

NCT05140746 ·Status: RECRUITING ·Phase: NA

New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

NCT01053390 ·Status: COMPLETED ·Phase: PHASE3

The Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After Operation

NCT03485196 ·Status: COMPLETED

The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer

NCT06235164 ·Status: ACTIVE_NOT_RECRUITING

Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer

NCT07025174 ·Status: RECRUITING ·Phase: PHASE2

Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer

NCT00675194 ·Status: COMPLETED ·Phase: PHASE2

A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy Regimen

NCT01070290 ·Status: WITHDRAWN ·Phase: PHASE2

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

NCT02301481 ·Status: COMPLETED ·Phase: PHASE2

Application Value of CTCs Detection for Advanced Gastric Cancer Patients

NCT03156777 ·Status: UNKNOWN

Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC

NCT03061058 ·Status: UNKNOWN ·Phase: PHASE3

Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer

NCT01515748 ·Status: COMPLETED ·Phase: PHASE3

Resistance to Immunotherapy in Gastric Cancer

NCT03614013 ·Status: UNKNOWN

A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China

NCT01472250 ·Status: COMPLETED

Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision Making

NCT03413514 ·Status: UNKNOWN ·Phase: NA

Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract

NCT00353015 ·Status: COMPLETED ·Phase: PHASE2